– Georgia is increasingly becoming a strategic hub for pharmaceutical and medical products export and re-export thanks to its geographic position, logistics capabilities, and GDP-certified supply chain infrastructure. RePharma is at the forefront of this transformation, offering comprehensive B2B export solutions that include consultancy, warehousing, logistics, and full supply chain support for branded and high-demand products.

Our core strength lies in our ability to enable Georgian pharmaceutical exports to any global destination by leveraging international trade expertise, GDP-compliant procedures, and strong market intelligence.

Strategic Focus: Global Export, Not Just One Destination

RePharma does not limit its export activities to a single region. While some markets show strong existing demand, our infrastructure and B2B network support export to a wide range of destinations. Based on export activity data and commercial demand signals, the top 5 export market destinations for Georgian pharmaceutical and medical products include:

  1. Libya – established demand and recurring commercial partnerships.

  2. Uzbekistan – strong healthcare procurement and distribution pipelines.

  3. Azerbaijan – close regional trade synergy and logistic connectivity.

  4. Armenia – cross-border medical product flows and complementary market needs.

  5. Kazakhstan – large market with growing import requirements for quality-assured products.

These markets underline that Georgia’s export footprint extends across Central Asia, the Caucasus, and parts of Africa and the Middle East, supporting regional and intercontinental trade expansion.

Top 10 Most Exported Pharmaceutical and Medical Products

RePharma’s export portfolio is diversified across in-demand product categories. While we do not highlight specific shipment volumes in this overview, the following top 10 product types consistently feature in Georgian export flows and commercial export strategies:

  1. Amoxicillin-Clavulanate (Augmentin) and Antibiotic Preparations – key therapeutic category with broad clinical use.

  2. Digital and Clinical Thermometers – high demand in institutional and retail channels.

  3. Pulse Oximeters – essential monitoring devices in hospitals, clinics, and home healthcare.

  4. Blood Pressure Monitors – widely used cardiovascular health measurement devices.

  5. Medical Disinfection and Sanitization Products – critical for healthcare settings and public health compliance.

  6. Diagnostic Test Kits (Rapid Tests) – used in broad clinical and field screening.

  7. Professional First Aid and Wound Care Kits – demand in emergency and outpatient care.

  8. Personal Protective and Safety Equipment – including masks, gloves, and related supplies.

  9. OTC Medical Supplies – over-the-counter healthcare products with stable consumer demand.

  10. Specialized Hospital Consumables – for surgical and inpatient care facilities.

These product categories demonstrate RePharma’s diversified export strategy, moving beyond traditional pharmaceutical APIs to include medical devices, OTC products, and consumables that meet international demand and regulatory expectations.

Why Choose RePharma for Pharmaceutical Export

RePharma’s export ecosystem is built on high-quality standards, regulatory compliance, and global market access:

  • GDP-Certified Logistics — ensuring product integrity across storage and distribution.

  • Integrated Supply Chain Solutions — from warehousing to customs and freight.

  • B2B Export Consultancy — supporting registration, market entry, and partner onboarding.

  • Scalable Infrastructure — capable of serving large institutional buyers and government tenders.

  • Reputation and Trust — recognized by partners domestically and internationally for reliability and responsiveness.

By aligning with RePharma, partners benefit from a partner that not only moves products but also manages complexities of international pharmaceutical trade.

Georgia as an Export Platform

Georgia serves as an efficient gateway for pharmaceutical trade into adjacent and distant markets due to:

  • Strategic location linking Europe, Asia, the Middle East, and Africa.

  • Favorable trade logistics and shorter transit times compared to many exporters.

  • Competitive cost structures and expanding logistics networks.

  • Growing recognition as a compliant exporter of medical products.

These advantages position Georgia — and RePharma specifically — to serve as a global export facilitator, not confined to regional supply but capable of reaching any destination based on demand.

Conclusion

RePharma’s export capabilities are defined by a comprehensive export architecture that includes consulting, logistics, warehousing, and market development. With a diversified product portfolio and strategic focus on expanding into multiple global markets beyond traditional axes, RePharma is equipped to advance Georgia’s footprint in the global pharmaceutical supply chain.

Whether entering new markets or expanding existing commercial presence, RePharma provides end-to-end solutions for pharmaceutical and medical product export, enabling trusted access to healthcare markets worldwide.